NORWOOD, MA — (Marketwired) — 12/05/16 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stageREAD MORE…
At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.
Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.
Cyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute Leukemia
BERKELEY HEIGHTS, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceuticalREAD MORE…
GAITHERSBURG, Md., Nov. 30, 2016 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in the CitiREAD MORE…